If switching from semaglutide (half-life ~7 days) to tirzepatide (half-life ~5 days), your provider may reduce the semaglutide dose, wait several days for clearance, then begin tirzepatide at its starting dose
(1984), and Chambers et al
Most people see initial results within the first week , with significant changes becoming apparent by weeks four to eight as steady state is established
IBS presents in several subtypes, often classified using the Bristol Stool Chart: IBS with constipation (IBS-C) : Predominant hard or lumpy stools IBS with diarrhoea (IBS-D) : Predominant loose or watery stools IBS with mixed bowel habits (IBS-M) : Alternating constipation and diarrhoea IBS unclassified (IBS-U) : Insufficient abnormality of stool consistency Common symptoms include bloating, abdominal distension, urgency, and a sensation of incomplete evacuation
What distinguishes Ipamorelin from other GHRPs (such as GHRP-6 or GHRP-2) is its exceptional selectivity : No significant cortisol increase: Unlike GHRP-6, Ipamorelin does not meaningfully elevate cortisol a stress hormone that can counteract GH benefits No prolactin stimulation: Elevated prolactin can interfere with reproductive hormones
